Abstract:Liuyi Huang, &ast Xi Li, &ast Wei Zhou, Haiqing Zhu, Yuehong Lao, Xiaoxia Huang, Zhenjia Deng, Yuting Tang, Jian Wang Department of Clinical Laboratory, the First Affiliated Hospital of Guangxi Medical University, Key Laboratory of Clinical Laboratory Medicine of Guangxi Department of Education, Nanning, Guangxi, 530021, People's Republic of China &astThese authors contributed equally to this work Correspondence: Jian Wang, Department of Clinical Laboratory, the First Affiliated Hospital of Guangxi Medical University, Key Laboratory of Clinical Laboratory Medicine of Guangxi Department of Education, No. 6 Shuangyong Road, Nanning, Guangxi, 530021, People's Republic of China, Email Objective: There are no studies examining the role of the neutrophil-to-lymphocyte ratio (NLR), the C-reactive protein-to-albumin ratio (CAR), the systemic inflammatory index (SII), and the systemic inflammatory response index (SIRI) in anti-synthetase syndrome (ASS). We aim to compare NLR, CAR, SII, and SIRI in ASS and dermatomyositis/polymyositis (DM/PM), as well as to examine potential correlations between NLR, CAR, SII, and SIRI and clinical features and laboratory parameters in ASS. Methods: Retrospective collection of data from 111 patients with ASS and 175 patients with DM/PM. A Spearman rank correlation analysis was utilized to analyze the correlation between NLR, CAR, SII, and SIRI and inflammatory indexes. Receiver operating characteristic (ROC) curves were used to assess the diagnostic value. Univariate logistic regression analysis was performed to assess risk factors for interstitial lung disease (ILD). Results: Compared with DM/PM, NLR, CAR, SII, and SIRI were significantly greater in ASS patients (p < 0.05). NLR, CAR, SII, and SIRI were correlated with albumin, lactic dehydrogenase (LDH), C-reactive protein (CRP), ferritin, white blood cell (WBC), platelets, and myositis disease activity assessment visual analog scales (MYOACT) score (p < 0.05). The ROC curves analysis showed that NLR, SII, and SIRI were all highly predictive of the occurrence of ASS. Comparisons based on clinical characteristics showed elevated levels of NLR, CAR, SII, and SIRI in ASS patients with ILD, fever, and infection (p < 0.05). Univariate logistic regression analysis revealed that NLR, CAR, and SII were significant risk factors for ASS-ILD (p < 0.05). Conclusion: The levels of NLR, CAR, SII, and SIRI were higher in ASS than in DM/PM and correlated with disease activity and specific clinical features. NLR, CAR, SII, and SIRI may be an aid in differentiating ASS from DM/PM and maybe promising biomarkers for ASS. Keywords: the neutrophil-to-lymphocyte ratio, the C-reactive protein-to-albumin ratio, the systemic immune inflammation index, the systemic inflammation response index, anti-synthase syndrome Idiopathic inflammatory myopathy (IIM) mainly includes dermatomyositis (DM), polymyositis (PM), anti-synthetase syndrome (ASS), immune-mediated necrotizing myopathy (IMNM), inclusion body myositis (IBM). 1 DM is the most common subtype of IIM, accounting for about 30–40% of IIMs. 2 DM is characterized by proximal muscle weakness and rash. In addition, myositis-specific antibody (MSA) is found in 60% of DM. 3 Clinical signs of PM are dominated by muscle abnormalities, while skin inflammation is less typical. 4 The definition of PM remains controversial, with ASS and IMNM being categorized as PM before MSA was discovered. 3,5 ASS is a newly classified clinical subtype of IIM characterized by the presence of anti-aminoacyl transfer RNA synthetase (ARS), and eight different isoforms targeting ARS have been identified, including Jo-1, OJ, PL-7, PL-12, KS, EJ, Ha, and Zo. 6–8 Interstitial lung disease (ILD) is the most prevalent clinical symptom of ASS, however, other symptoms include arthritis, myositis, and systemic symptoms including fever. Compared to DM/PM, ASS-ILD is more common and severe, with more extensive pulmonary involvement and faster onset of pulmonary symptoms. 9 Although ASS shares many features with DM/PM, it has a distinctive serologic and clinical presentation. The European Neuromuscular Centre (ENMC) states that even though there is an overlap in clinical presentation between ASS and DM, ASS is a distinct subgroup separate from DM/PM. 10 However, there are no recognized classification criteria. Therefore, further search for relevant biomarkers that can identify IIM subtypes is necessary. Researchers around the world are exploring these factors in different contexts. The neutrophil-to-lymphocyte ratio (NLR), the C-reactive protein-to-albumin ratio (CAR), the systemic inflammatory index (SII), and the systemic inflamm -Abstract Truncated-

Single-Cell Transcriptomics Reveals Peripheral Immune Responses in Anti-Synthetase Syndrome-Associated Interstitial Lung Disease

Peripheral Th17/Treg imbalance in Chinese patients with untreated antisynthetase syndrome associated interstitial lung disease

Aberrant T Cell Subsets and Cytokines Expression Profile in Systemic Lupus Erythematosus.

Dysregulated T Cell Activation and Aberrant Cytokine Expression Profile in Systemic Lupus Erythematosus.

Clinical features of anti-synthetase syndrome associated interstitial lung disease: a retrospective cohort in China

Clinical characteristics of patients with anti-EJ antisynthetase syndrome associated interstitial lung disease and literature review

Prediction of progressive pulmonary fibrosis in patients with anti-synthetase syndrome-associated interstitial lung disease

FRI0450 Associations of alterations of peripheral regulatory t and th17 absolute cell numbers with clinical features in patients with systemic sclerosis

Serum biomarker-based risk model construction for primary Sjögren's syndrome with interstitial lung disease

Relationship between high-resolution computed tomography quantitative imaging analysis and physiological and clinical features in antisynthetase syndrome-related interstitial lung disease

DIFFERENTIAL EXPRESSION OF PERIPHERAL CD4+T CELLS IN PATIENTS WITH SYSTEMIC SCLEROSIS AND MIXED CONNECTIVE TISSUE DISEASE

An Observational Study on the Clinical Characteristics and Prognosis of Patients With Interstitial Lung Disease Secondary to Dermatomyositis and Antisynthetase Syndrome

Natural history of indolent-anti-synthetase syndrome-associated interstitial lung disease

Unique transcriptomic profile of peripheral blood monocytes in rheumatoid arthritis-associated interstitial lung disease

Novel endotypes of antisynthetase syndrome identified independent of anti-aminoacyl transfer RNA synthetase antibody specificity that improve prognostic stratification

The Clinical Value of the Neutrophil-to-Lymphocyte Ratio, the C-Reactive Protein-to-Albumin Ratio, the Systemic Inflammatory Index, and the Systemic Inflammatory Response Index in Patients with the Anti-Synthetase Syndrome

Macrophages as determinants and regulators of systemic sclerosis-related interstitial lung disease

Disparate Interferon Signaling and Shared Aberrant Basaloid Cells in Single-Cell Profiling of Idiopathic Pulmonary Fibrosis and Systemic Sclerosis-Associated Interstitial Lung Disease

Identification and functional prediction of long non-coding RNA and mRNA related to connective tissue disease-associated interstitial lung diseases

Comparison of Cytokine/chemokine Profiles Between Dermatomyositis and Anti-Synthetase Syndrome

Single-Cell RNA Sequencing Reveals the Expansion of Cytotoxic CD4+ T Lymphocytes and a Landscape of Immune Cells in Primary Sjögren’s Syndrome